The Latest Breaking News from Organigram

Organigram Global Q2 Earnings Call Highlights

Organigram Global (NASDAQ:OGI) reported a weaker second quarter for fiscal 2026, with management attributing the decline to operational issues in key product categories, softer Canadian cannabis market growth and continued challenges with international flower specifications. Chief Executive Officer

MarketBeat · May 12

OrganiGram (OGI) Joins Cannabis Stock Rally After Trump Signals Policy Shift

Organigram Global Inc (NASDAQ: OGI) shares are trading sharply higher Monday afternoon, joining a rally across the cannabis sector.

Benzinga · Sep 29, 2025

Organigram Posts Wider Loss, Eyes Profitability In Near Term

Cannabis grower Organigram Holdings Inc. (NASDAQ:OGI) reported third-quarter 2025 net sales of $51.14 million, approximately $70.8 million Canadian dollars (CAD), up 72% year-over-year, beating the consensus of $48.33 million.

Benzinga · Aug 13, 2025

3 Tobacco Stocks Gaining Traction in 2024

Despite encountering various challenges, the tobacco industry thrives on sustained consumption and the introduction of innovative products. Therefore, investors could consider buying fundamentally strong tobacco stocks Vector Group (VGR), Universal (UVV), and British American Tobacco (BTI). Read on….

StockNews.com · Jan 8, 2024

3 Tobacco Stock Picks for December Portfolio Prosperity

Despite various challenges, the tobacco industry thrives on sustained consumption. Moreover, introducing new products is expected to boost the industry’s long-term prospects. Therefore, investors could look to invest in the fundamentally strong tobacco stocks Vector Group (VGR), British American Tobacco (BTI), and Turning Point Brands (TPB). Read on….

StockNews.com · Dec 4, 2023

3 Cannabis Stocks to Consider Buying as HHS Recommends Easing Restrictions on Marijuana

Cannabis stocks could deliver outsized gains if marijuana is rescheduled, per a recent HHS recommendation. While the DEA weighs its options, here's a look at three names with significant upside potential, according to analysts.

Barchart · Sep 7, 2023

Want Exposure To The Canadian Recreational Cannabis Market? These Are The 3 Best Picks, According To A Cantor Analyst

In a recent analyst note, Pablo Zuanic from Cantor Fitzgerald offered an update on the performance of Canada’s cannabis Licensed Producers in the August quarter, based on data obtained by the market scanner Hifyre.

Benzinga · Sep 14, 2022

This Analyst Expects Stabilization Across Canadian Cannabis Market, Revises Sales Estimates For Cannabis LPs

The Canadian cannabis industry has become a competitive field over the past few years, which doesn’t come as a surprise considering its exponential growth over the same period.

Benzinga · Jul 21, 2022

OrganiGram Beat Fact Set Expectations: "The Stock Represents Good Value," Analyst Says

On Thursday, Organigram Holdings Inc. (OGI.TO) (NASDAQ: OGI), a cannabis company focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada,

Benzinga · Jul 14, 2022

2Q Canada Recreational Cannabis Market Analysis: +21 YoY Growth Outperforming The U.S.

In a recent analyst note, Cantor Fitzgerald's Pablo Zuanic gave an overview of the Canadian recreational cannabis market in the second quarter of 2022, according to data collected by Hifyre, a leading in-shop and online digital toolset for cannabis dispensaries.

Benzinga · Jul 14, 2022